Nexalin Technology (NXL) Enterprise Value (2022 - 2026)
Nexalin Technology (NXL) posted Enterprise Value of -$762917.2 for Q2 2026, up 72.37% on a QoQ basis from -$2.8 million in Q1 2026, and up 92.48% year-over-year from -$396357.3 in Q2 2025.
Analysis
Nexalin Technology (NXL) Enterprise Value (2022 - 2026) Analysis & Trends
Nexalin Technology has reported Enterprise Value for 5 years, with the latest figure at -$762917.2 in Q2 2026.
- On a quarterly basis, Enterprise Value rose 92.48% year-over-year to -$762917.2 in Q2 2026; TTM through Jun 2026 was -$762917.2, a 92.48% increase from a year earlier, with the FY2025 full-year figure at -$5.8 million, down 16.44% from the prior year.
- Enterprise Value was -$762917.2 for Q2 2026 at Nexalin Technology, up from -$2.8 million in the prior quarter.
- The five-year high for Enterprise Value was -$421420.3 in Q2 2024, with the low at -$13.5 million in Q4 2022.
- Average Enterprise Value over 5 years is -$6.1 million, with a median of -$6.4 million recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 95.16% in 2024, then tumbled 2308.08% in 2025.
- Over 5 years, Enterprise Value stood at -$13.5 million in 2022, then soared by 65.73% to -$4.6 million in 2023, then decreased by 7.08% to -$5.0 million in 2024, then fell by 16.44% to -$5.8 million in 2025, then soared by 86.8% to -$762917.2 in 2026.
- The last three Enterprise Value figures came in at -$762917.2 (Q2 2026), -$2.8 million (Q1 2026), and -$5.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -762,917.18 |
| Mar 31, 2026 | -2.76 Mn |
| Dec 31, 2025 | -5.78 Mn |
| Sep 30, 2025 | -6.97 Mn |
| Jun 30, 2025 | -10.15 Mn |
| Mar 31, 2025 | -1.99 Mn |
| Dec 31, 2024 | -4.96 Mn |
| Sep 30, 2024 | -8.74 Mn |
| Jun 30, 2024 | -421,420.34 |
| Mar 31, 2024 | -2.85 Mn |
| Dec 31, 2023 | -4.63 Mn |
| Sep 30, 2023 | -7.04 Mn |
| Jun 30, 2023 | -8.71 Mn |
| Mar 31, 2023 | -10.40 Mn |
| Dec 31, 2022 | -13.52 Mn |
| Sep 30, 2022 | -7.68 Mn |